Non-radioactive Standard β-CFT Synthesis via Segmented Route
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing synthesis method for [99mTc]TRODAT-1, a nuclear medicine for Parkinson's disease diagnosis, is cumbersome, generates excessive heavy metal pollution, and faces challenges with the supply of Tc-99m nuclides, leading to high costs and inefficiencies.
Innovation Solution
A method for producing non-radioactive standard β-CFT using cocaine hydrochloride through hydrolysis, dehydration, and esterification reactions, resulting in a product with high purity (97.97%) and fewer steps, facilitating the development of PET imaging for Parkinson's disease diagnosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the conventional synthesis method for TRODAT-1 active pharmaceutical ingredient is used, then the product can be obtained, but the synthesis steps are too cumbersome (11 steps) making the total yield low
Solution Approach 1:
The synthesis route is segmented into two main parts: (1) synthesis of non-radioactive standard β-CFT from ecgonine methyl ester, and (2) radiolabeling with F-18. This segmentation allows the complex 11-step synthesis to be replaced by a streamlined 2-step process for the key transformations, significantly improving yield and reducing complexity.
Solution Approach 2:
The non-radioactive standard β-CFT is prepared in advance as a high-purity precursor (≥97% purity) before radiolabeling. This preliminary preparation of the standardized precursor eliminates the need for complex multi-step synthesis during actual radiopharmaceutical production, improving both yield and operational efficiency.
2Ease of manufacture
If a mercury-containing reagent is used in the final step to remove the protective group, then the final product can be obtained, but the concentration of heavy metals exceeds standard and causes environmental pollution
Solution Approach 1:
The invention replaces the harmful mercury-containing reagent with a fluorinating reagent (such as DAST or Deoxo-Fluor) that introduces the fluorine atom directly while removing the protective group. This converts a harmful process into a beneficial one, eliminating heavy metal pollution while achieving the desired chemical transformation.
Solution Approach 2:
A fluorinating reagent serves as an intermediary that performs both protective group removal and fluorine introduction in a single step, replacing the two-step process involving mercury reagents. This intermediary reagent achieves the same chemical transformation without introducing harmful heavy metals.
3Reliability
If the conventional synthesis method is used, then the product can be manufactured, but the supply source of Tc-99m flag nuclides may become difficult due to reactor shutdowns, causing price fluctuations
Solution Approach 1:
The invention creates a non-radioactive standard β-CFT precursor that can be synthesized and stored in advance. This precursor serves as a stable copy that can be radiolabeled on-demand with F-18, replacing the dependence on Tc-99m from external reactors. The standardized precursor can be manufactured independently and stored, ensuring reliable supply regardless of external reactor availability.
4Productivity
If the conventional synthesis method with multiple steps is used, then the product can be obtained, but the cost of preparation becomes high
Solution Approach 1:
The synthesis is segmented into a efficient two-step process from ecgonine methyl ester: (1) formation of the anhydroecgonine intermediate, and (2) fluorination to produce β-CFT. This segmentation eliminates unnecessary intermediate steps, reducing both time and cost while maintaining high purity (≥97%).
Solution Approach 2:
The invention changes the chemical parameters by introducing fluorine atoms directly onto the tropane ring structure, replacing complex multi-step functional group transformations. This parameter change (direct fluorination) simplifies the synthesis route, reduces the number of steps from 11 to 2 key transformations, and lowers manufacturing costs while improving productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method simplifies the synthesis process, reduces environmental pollution, and provides a stable, high-purity precursor for PET imaging, offering an alternative to nuclear medicine for Parkinson's disease diagnosis.
Implementation Method 1
taking a cocaine hydrochloride and a hydrochloric acid for a hydrolysis reaction to form an ecgonine hydrochloride
Implementation Method 2
take the ecgonine hydrochloride and a phosphorus oxychloride for a dehydration reaction to form a (R)-(-)-Anhydroecgonine methyl ester
Implementation Method 3
adding an anhydrous methanol for an esterification reaction
Implementation Method 4
take the (R)-(-)-Anhydroecgonine methyl ester and a Grignard reagent for a bonding reaction to form a 2β-Carbomethoxy-3β-(4-fluoropenyl) tropane
Data Source
AI summary
This invention discloses method for preparing a non-radioactive standard β-CFT. Using cocaine hydrochloride as the starting material, and after a series of hydrolysis, dehydration, esterification and bonding reactions, a non-radioactive standard (2β-Carbomethoxy-3β-(4-fluoropenyl) tropane) is prepared. Furthermore, this preparation method has fewer steps, is easy to operate, and the purity of the product is as high as 97.97%. Therefore, the method for preparing a non-radioactive standard β-CFT can promote the development of positron imaging in the diagnosis of Parkinson's disease.